To evaluate whether IGF2BP3 was required for the effect of STRIP2 on NSCLC progression, we knocked down IGF2BP3 expression in PC9 cells, and then overexpressed STRIP2 in these cells (Fig. 7a). This evidence concerns the gene STRIP2 and non-small cell lung carcinoma.